Drug Classes: Convergent and Divergent Mechanisms

This section is represented as a source-backed SciDEX wiki artifact. The full source remains in the original computational-review repository.

Source: https://github.com/AllenNeuralDynamics/ComputationalReviewAddiction/blob/43d33061a22aa4fed3f7dc71fabbfa48ab1d6f48/content/05_drug_classes.md

Citation anchors captured: 132

Citation contexts

^{1Citationpaper:paper-75c4a42896baThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference} The dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a “final common pathway” to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...
^{2Citationpaper:paper-0369dc87df4bThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference} The dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a “final common pathway” to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...
^{3Citationpaper:paper-ce41cca278fdThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference} The dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a “final common pathway” to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...
^{4Citationpaper:paper-a776abe4441cThe textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference} The textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby “disinhibiting” dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...
^{5Citationpaper:paper-f91a4514f945The textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference} The textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby “disinhibiting” dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference} ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference} provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference} ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference} provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference} The canonical VTA disinhibition model (opioids suppress GABAergic interneurons → dopamine neuron disinhibition → increased DA release) has been challenged by findings showing direct opioid actions on dopamine neurons and extensive cell-type heterogeneity within the VTA ^{2Citationpaper:paper-0369dc87df4bThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}0. Direct MOR expression on dopamine neurons, heterogeneous projection patterns, and the involvement of glutama...
^{2Citationpaper:paper-0369dc87df4bThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}1 The canonical VTA disinhibition model (opioids suppress GABAergic interneurons → dopamine neuron disinhibition → increased DA release) has been challenged by findings showing direct opioid actions on dopamine neurons and extensive cell-type heterogeneity within the VTA ^{2Citationpaper:paper-0369dc87df4bThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}2. Direct MOR expression on dopamine neurons, heterogeneous projection patterns, and the involvement of glutama...
^{2Citationpaper:paper-0369dc87df4bThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}3 The canonical VTA disinhibition model (opioids suppress GABAergic interneurons → dopamine neuron disinhibition → increased DA release) has been challenged by findings showing direct opioid actions on dopamine neurons and extensive cell-type heterogeneity within the VTA ^{2Citationpaper:paper-0369dc87df4bThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}4. Direct MOR expression on dopamine neurons, heterogeneous projection patterns, and the involvement of glutama...
^{2Citationpaper:paper-0369dc87df4bThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}5 The canonical VTA disinhibition model (opioids suppress GABAergic interneurons → dopamine neuron disinhibition → increased DA release) has been challenged by findings showing direct opioid actions on dopamine neurons and extensive cell-type heterogeneity within the VTA ^{2Citationpaper:paper-0369dc87df4bThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}6. Direct MOR expression on dopamine neurons, heterogeneous projection patterns, and the involvement of glutama...
^{2Citationpaper:paper-0369dc87df4bThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}7 The canonical VTA disinhibition model (opioids suppress GABAergic interneurons → dopamine neuron disinhibition → increased DA release) has been challenged by findings showing direct opioid actions on dopamine neurons and extensive cell-type heterogeneity within the VTA ^{2Citationpaper:paper-0369dc87df4bThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}8. Direct MOR expression on dopamine neurons, heterogeneous projection patterns, and the involvement of glutama...
^{2Citationpaper:paper-0369dc87df4bThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}9 ^{3Citationpaper:paper-ce41cca278fdThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}0 extended this complexity by demonstrating that chemogenetic inhibition of VTA GABA neurons modulated morphine conditioned place preference (CPP) in mice, and that adolescent nicotine exposure enhanced morphine CPP, choice-based morphine consumption, and locomotor sensitization in adulthood — establishing cross-drug developmental interactions that the simple disinhibition model cannot accommodate [Wi...
^{3Citationpaper:paper-ce41cca278fdThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}1 ^{3Citationpaper:paper-ce41cca278fdThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}2 extended this complexity by demonstrating that chemogenetic inhibition of VTA GABA neurons modulated morphine conditioned place preference (CPP) in mice, and that adolescent nicotine exposure enhanced morphine CPP, choice-based morphine consumption, and locomotor sensitization in adulthood — establishing cross-drug developmental interactions that the simple disinhibition model cannot accommodate [Wi...
^{3Citationpaper:paper-ce41cca278fdThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}3 ^{3Citationpaper:paper-ce41cca278fdThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}4 extended this complexity by demonstrating that chemogenetic inhibition of VTA GABA neurons modulated morphine conditioned place preference (CPP) in mice, and that adolescent nicotine exposure enhanced morphine CPP, choice-based morphine consumption, and locomotor sensitization in adulthood — establishing cross-drug developmental interactions that the simple disinhibition model cannot accommodate [Wi...
^{3Citationpaper:paper-ce41cca278fdThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}5 ^{3Citationpaper:paper-ce41cca278fdThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}6 extended this complexity by demonstrating that chemogenetic inhibition of VTA GABA neurons modulated morphine conditioned place preference (CPP) in mice, and that adolescent nicotine exposure enhanced morphine CPP, choice-based morphine consumption, and locomotor sensitization in adulthood — establishing cross-drug developmental interactions that the simple disinhibition model cannot accommodate [Wi...
^{3Citationpaper:paper-ce41cca278fdThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}7 ^{3Citationpaper:paper-ce41cca278fdThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}8 extended this complexity by demonstrating that chemogenetic inhibition of VTA GABA neurons modulated morphine conditioned place preference (CPP) in mice, and that adolescent nicotine exposure enhanced morphine CPP, choice-based morphine consumption, and locomotor sensitization in adulthood — establishing cross-drug developmental interactions that the simple disinhibition model cannot accommodate [Wi...
^{3Citationpaper:paper-ce41cca278fdThe dopamine-centric frameworks examined in {ref}sec-dopamine-dynamics rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...content/05_drug_classes.md:line 5Open reference}9 ^{4Citationpaper:paper-a776abe4441cThe textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}0 extended this complexity by demonstrating that chemogenetic inhibition of VTA GABA neurons modulated morphine conditioned place preference (CPP) in mice, and that adolescent nicotine exposure enhanced morphine CPP, choice-based morphine consumption, and locomotor sensitization in adulthood — establishing cross-drug developmental interactions that the simple disinhibition model cannot accommodate [Wi...
^{4Citationpaper:paper-a776abe4441cThe textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}1 ^{4Citationpaper:paper-a776abe4441cThe textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}2 extended this complexity by demonstrating that chemogenetic inhibition of VTA GABA neurons modulated morphine conditioned place preference (CPP) in mice, and that adolescent nicotine exposure enhanced morphine CPP, choice-based morphine consumption, and locomotor sensitization in adulthood — establishing cross-drug developmental interactions that the simple disinhibition model cannot accommodate [Wi...
^{4Citationpaper:paper-a776abe4441cThe textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}3 ^{4Citationpaper:paper-a776abe4441cThe textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}4 extended this complexity by demonstrating that chemogenetic inhibition of VTA GABA neurons modulated morphine conditioned place preference (CPP) in mice, and that adolescent nicotine exposure enhanced morphine CPP, choice-based morphine consumption, and locomotor sensitization in adulthood — establishing cross-drug developmental interactions that the simple disinhibition model cannot accommodate [Wi...
^{4Citationpaper:paper-a776abe4441cThe textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}5 ^{4Citationpaper:paper-a776abe4441cThe textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}6 extended this complexity by demonstrating that chemogenetic inhibition of VTA GABA neurons modulated morphine conditioned place preference (CPP) in mice, and that adolescent nicotine exposure enhanced morphine CPP, choice-based morphine consumption, and locomotor sensitization in adulthood — establishing cross-drug developmental interactions that the simple disinhibition model cannot accommodate [Wi...
^{4Citationpaper:paper-a776abe4441cThe textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}7 A critical gap in the current evidence base concerns fentanyl-specific circuit mechanisms. Despite fentanyl’s centrality to the current opioid overdose crisis, most preclinical circuit-level studies have used morphine as the prototypical opioid ^{4Citationpaper:paper-a776abe4441cThe textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}8. Whether fentanyl’s distinct pharmacokinetic profile — faster onset, higher potency, different receptor binding kinetics — engages different circuit...
^{4Citationpaper:paper-a776abe4441cThe textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}9 A critical gap in the current evidence base concerns fentanyl-specific circuit mechanisms. Despite fentanyl’s centrality to the current opioid overdose crisis, most preclinical circuit-level studies have used morphine as the prototypical opioid ^{5Citationpaper:paper-f91a4514f945The textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}0. Whether fentanyl’s distinct pharmacokinetic profile — faster onset, higher potency, different receptor binding kinetics — engages different circuit...
^{5Citationpaper:paper-f91a4514f945The textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}1 A critical gap in the current evidence base concerns fentanyl-specific circuit mechanisms. Despite fentanyl’s centrality to the current opioid overdose crisis, most preclinical circuit-level studies have used morphine as the prototypical opioid ^{5Citationpaper:paper-f91a4514f945The textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}2. Whether fentanyl’s distinct pharmacokinetic profile — faster onset, higher potency, different receptor binding kinetics — engages different circuit...
^{5Citationpaper:paper-f91a4514f945The textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}3 A critical gap in the current evidence base concerns fentanyl-specific circuit mechanisms. Despite fentanyl’s centrality to the current opioid overdose crisis, most preclinical circuit-level studies have used morphine as the prototypical opioid ^{5Citationpaper:paper-f91a4514f945The textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}4. Whether fentanyl’s distinct pharmacokinetic profile — faster onset, higher potency, different receptor binding kinetics — engages different circuit...
^{5Citationpaper:paper-f91a4514f945The textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}5 A critical gap in the current evidence base concerns fentanyl-specific circuit mechanisms. Despite fentanyl’s centrality to the current opioid overdose crisis, most preclinical circuit-level studies have used morphine as the prototypical opioid ^{5Citationpaper:paper-f91a4514f945The textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}6. Whether fentanyl’s distinct pharmacokinetic profile — faster onset, higher potency, different receptor binding kinetics — engages different circuit...
^{5Citationpaper:paper-f91a4514f945The textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}7 A critical gap in the current evidence base concerns fentanyl-specific circuit mechanisms. Despite fentanyl’s centrality to the current opioid overdose crisis, most preclinical circuit-level studies have used morphine as the prototypical opioid ^{5Citationpaper:paper-f91a4514f945The textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}8. Whether fentanyl’s distinct pharmacokinetic profile — faster onset, higher potency, different receptor binding kinetics — engages different circuit...
^{5Citationpaper:paper-f91a4514f945The textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...content/05_drug_classes.md:line 9Open reference}9 Among all drug classes, stimulants — cocaine and amphetamines — provide the strongest support for the dopamine convergence model. Cocaine directly blocks the dopamine transporter (DAT), and amphetamines reverse DAT function, both producing rapid, large increases in synaptic dopamine concentrations. If any drug class should validate the “final common pathway,” it is this one. Yet even here, the mechanisms extend well...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}0 Among all drug classes, stimulants — cocaine and amphetamines — provide the strongest support for the dopamine convergence model. Cocaine directly blocks the dopamine transporter (DAT), and amphetamines reverse DAT function, both producing rapid, large increases in synaptic dopamine concentrations. If any drug class should validate the “final common pathway,” it is this one. Yet even here, the mechanisms extend well...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}1 Among all drug classes, stimulants — cocaine and amphetamines — provide the strongest support for the dopamine convergence model. Cocaine directly blocks the dopamine transporter (DAT), and amphetamines reverse DAT function, both producing rapid, large increases in synaptic dopamine concentrations. If any drug class should validate the “final common pathway,” it is this one. Yet even here, the mechanisms extend well...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}2 ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}3 demonstrated in rats that compulsive, punishment-resistant cocaine-seeking habits were associated with a reduction in DAT mRNA levels specifically in the NAc shell, but not in the NAc core or dorsolateral striatum (DLS) incentive habit system. This subregional specificity — within a structure often treated as a uniform target — challenges the notion that stimulant addiction is simply a matter of "too...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}4 ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}5 demonstrated in rats that compulsive, punishment-resistant cocaine-seeking habits were associated with a reduction in DAT mRNA levels specifically in the NAc shell, but not in the NAc core or dorsolateral striatum (DLS) incentive habit system. This subregional specificity — within a structure often treated as a uniform target — challenges the notion that stimulant addiction is simply a matter of "too...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}6 ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}7 demonstrated in rats that compulsive, punishment-resistant cocaine-seeking habits were associated with a reduction in DAT mRNA levels specifically in the NAc shell, but not in the NAc core or dorsolateral striatum (DLS) incentive habit system. This subregional specificity — within a structure often treated as a uniform target — challenges the notion that stimulant addiction is simply a matter of "too...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}8 ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}9 demonstrated in rats that compulsive, punishment-resistant cocaine-seeking habits were associated with a reduction in DAT mRNA levels specifically in the NAc shell, but not in the NAc core or dorsolateral striatum (DLS) incentive habit system. This subregional specificity — within a structure often treated as a uniform target — challenges the notion that stimulant addiction is simply a matter of "too...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}0 Glutamatergic plasticity in the prefrontal cortex (PFC)-to-NAc pathway plays a prominent role in cocaine relapse. N-acetylcysteine (NAC), a glutamate-modulating agent, significantly reduced cocaine-seeking behavior on the first day of extinction in rats, though this effect did not persist in subsequent sessions ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}1. The therapeutic potential of glutamate-modulating agents for treating comorbid stress and co...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}2 Glutamatergic plasticity in the prefrontal cortex (PFC)-to-NAc pathway plays a prominent role in cocaine relapse. N-acetylcysteine (NAC), a glutamate-modulating agent, significantly reduced cocaine-seeking behavior on the first day of extinction in rats, though this effect did not persist in subsequent sessions ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}3. The therapeutic potential of glutamate-modulating agents for treating comorbid stress and co...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}4 Glutamatergic plasticity in the prefrontal cortex (PFC)-to-NAc pathway plays a prominent role in cocaine relapse. N-acetylcysteine (NAC), a glutamate-modulating agent, significantly reduced cocaine-seeking behavior on the first day of extinction in rats, though this effect did not persist in subsequent sessions ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}5. The therapeutic potential of glutamate-modulating agents for treating comorbid stress and co...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}6 Glutamatergic plasticity in the prefrontal cortex (PFC)-to-NAc pathway plays a prominent role in cocaine relapse. N-acetylcysteine (NAC), a glutamate-modulating agent, significantly reduced cocaine-seeking behavior on the first day of extinction in rats, though this effect did not persist in subsequent sessions ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}7. The therapeutic potential of glutamate-modulating agents for treating comorbid stress and co...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}8 Glutamatergic plasticity in the prefrontal cortex (PFC)-to-NAc pathway plays a prominent role in cocaine relapse. N-acetylcysteine (NAC), a glutamate-modulating agent, significantly reduced cocaine-seeking behavior on the first day of extinction in rats, though this effect did not persist in subsequent sessions ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}9. The therapeutic potential of glutamate-modulating agents for treating comorbid stress and co...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}0 Glutamatergic plasticity in the prefrontal cortex (PFC)-to-NAc pathway plays a prominent role in cocaine relapse. N-acetylcysteine (NAC), a glutamate-modulating agent, significantly reduced cocaine-seeking behavior on the first day of extinction in rats, though this effect did not persist in subsequent sessions ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}1. The therapeutic potential of glutamate-modulating agents for treating comorbid stress and co...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}2 Alcohol presents a fundamental challenge to the single-target model that underpins addiction pharmacology for other drug classes. Unlike opioids (MOR), stimulants (DAT), nicotine (nAChR), or cannabis (CB1), alcohol acts on multiple molecular systems simultaneously — GABA-A receptors, NMDA receptors, endogenous opioid peptides, nicotinic acetylcholine receptors (nAChRs), 5-HT3 receptors, and GIRK channels, among othe...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}3 Alcohol presents a fundamental challenge to the single-target model that underpins addiction pharmacology for other drug classes. Unlike opioids (MOR), stimulants (DAT), nicotine (nAChR), or cannabis (CB1), alcohol acts on multiple molecular systems simultaneously — GABA-A receptors, NMDA receptors, endogenous opioid peptides, nicotinic acetylcholine receptors (nAChRs), 5-HT3 receptors, and GIRK channels, among othe...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}4 Alcohol presents a fundamental challenge to the single-target model that underpins addiction pharmacology for other drug classes. Unlike opioids (MOR), stimulants (DAT), nicotine (nAChR), or cannabis (CB1), alcohol acts on multiple molecular systems simultaneously — GABA-A receptors, NMDA receptors, endogenous opioid peptides, nicotinic acetylcholine receptors (nAChRs), 5-HT3 receptors, and GIRK channels, among othe...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}5 Alcohol presents a fundamental challenge to the single-target model that underpins addiction pharmacology for other drug classes. Unlike opioids (MOR), stimulants (DAT), nicotine (nAChR), or cannabis (CB1), alcohol acts on multiple molecular systems simultaneously — GABA-A receptors, NMDA receptors, endogenous opioid peptides, nicotinic acetylcholine receptors (nAChRs), 5-HT3 receptors, and GIRK channels, among othe...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}6 Unlike other drugs with identified primary targets, alcohol acts on GABA-A, NMDA, endogenous opioid, nAChR, 5-HT3, and GIRK systems. Which system is primarily responsible for addiction liability remains unresolved. Without answering this question, pharmacotherapy for alcohol use disorder (AUD) remains empirical rather than mechanistically targeted ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}7.
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}8 Unlike other drugs with identified primary targets, alcohol acts on GABA-A, NMDA, endogenous opioid, nAChR, 5-HT3, and GIRK systems. Which system is primarily responsible for addiction liability remains unresolved. Without answering this question, pharmacotherapy for alcohol use disorder (AUD) remains empirical rather than mechanistically targeted ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}9.
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}0 Unlike other drugs with identified primary targets, alcohol acts on GABA-A, NMDA, endogenous opioid, nAChR, 5-HT3, and GIRK systems. Which system is primarily responsible for addiction liability remains unresolved. Without answering this question, pharmacotherapy for alcohol use disorder (AUD) remains empirical rather than mechanistically targeted ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}1.
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}2 The therapeutic implications of this ambiguity are illustrated by the contrast between naltrexone and nalmefene — both opioid receptor antagonists approved for AUD, yet with non-identical efficacy profiles. ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}3 developed a predictive model based on circulating biogenic amines that classifies nalmefene-versus-naltrexone responders with high accuracy, underscoring that even within the opioid-mediated com...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}4 The therapeutic implications of this ambiguity are illustrated by the contrast between naltrexone and nalmefene — both opioid receptor antagonists approved for AUD, yet with non-identical efficacy profiles. ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}5 developed a predictive model based on circulating biogenic amines that classifies nalmefene-versus-naltrexone responders with high accuracy, underscoring that even within the opioid-mediated com...
^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}6 The therapeutic implications of this ambiguity are illustrated by the contrast between naltrexone and nalmefene — both opioid receptor antagonists approved for AUD, yet with non-identical efficacy profiles. ^{6Citationpaper:paper-a77b6ea3644a[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...content/05_drug_classes.md:line 11Open reference}7 developed a predictive model based on circulating biogenic amines that classifies nalmefene-versus-naltrexone responders with high accuracy, underscoring that even within the opioid-mediated com...
... 82 additional anchors in refs_json

References

[Shankar2025] paper:paper-75c4a42896ba “The dopamine-centric frameworks examined in {ref}`sec-dopamine-dynamics` rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...”
[Wang2025g] paper:paper-0369dc87df4b “The dopamine-centric frameworks examined in {ref}`sec-dopamine-dynamics` rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...”
[Goto2026] paper:paper-ce41cca278fd “The dopamine-centric frameworks examined in {ref}`sec-dopamine-dynamics` rest on an implicit assumption: that all drugs of abuse ultimately converge on mesolimbic dopamine release as a "final common pathway" to addiction. This section tests that assumption drug by drug, examining the primary molecular targets, circuit engagement patterns, and neuroadaptive profiles of each major drug class. The evidence reveals that...”
[Reeves2022] paper:paper-a776abe4441c “The textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...”
[Capo2025] paper:paper-f91a4514f945 “The textbook account of opioid reward centers on a deceptively simple circuit: mu-opioid receptors (MORs) on GABAergic interneurons in the ventral tegmental area (VTA) are activated by opioids, suppressing inhibitory tone on dopaminergic neurons and thereby "disinhibiting" dopamine release into the nucleus accumbens (NAc). This VTA disinhibition model has been widely cited in reviews and textbooks for decades, yet t...”
[Oriol2025] paper:paper-a77b6ea3644a “[Oriol2025] provided one of the most direct challenges to the simplified disinhibition framework, demonstrating that VTA neurons genetically defined by expression of parvalbumin, somatostatin, neurotensin, or mu-opioid receptor project to known VTA targets including the NAc, ventral pallidum, lateral habenula, and prefrontal cortex. Critically, this work revealed that approximately 25% of VTA glutamate neurons co-ex...”
[Wittenberg2026] paper:paper-60cb9c0e699e “The canonical VTA disinhibition model (opioids suppress GABAergic interneurons → dopamine neuron disinhibition → increased DA release) has been challenged by findings showing direct opioid actions on dopamine neurons and extensive cell-type heterogeneity within the VTA [Oriol2025, Wittenberg2026, Reeves2022]. Direct MOR expression on dopamine neurons, heterogeneous projection patterns, and the involvement of glutama...”
[He2026] paper:paper-89ba008dc0cd “The canonical VTA disinhibition model (opioids suppress GABAergic interneurons → dopamine neuron disinhibition → increased DA release) has been challenged by findings showing direct opioid actions on dopamine neurons and extensive cell-type heterogeneity within the VTA [Oriol2025, Wittenberg2026, Reeves2022]. Direct MOR expression on dopamine neurons, heterogeneous projection patterns, and the involvement of glutama...”
[Durairaj2025] paper:paper-8212519aa0aa “The canonical VTA disinhibition model (opioids suppress GABAergic interneurons → dopamine neuron disinhibition → increased DA release) has been challenged by findings showing direct opioid actions on dopamine neurons and extensive cell-type heterogeneity within the VTA [Oriol2025, Wittenberg2026, Reeves2022]. Direct MOR expression on dopamine neurons, heterogeneous projection patterns, and the involvement of glutama...”
[Marchette2025] paper:paper-4f6bb7af9c17 “[Wittenberg2026] extended this complexity by demonstrating that chemogenetic inhibition of VTA GABA neurons modulated morphine conditioned place preference (CPP) in mice, and that adolescent nicotine exposure enhanced morphine CPP, choice-based morphine consumption, and locomotor sensitization in adulthood — establishing cross-drug developmental interactions that the simple disinhibition model cannot accommodate [Wi...”
[vandeWetering2025] paper:paper-33978d0e94fe “[Wittenberg2026] extended this complexity by demonstrating that chemogenetic inhibition of VTA GABA neurons modulated morphine conditioned place preference (CPP) in mice, and that adolescent nicotine exposure enhanced morphine CPP, choice-based morphine consumption, and locomotor sensitization in adulthood — establishing cross-drug developmental interactions that the simple disinhibition model cannot accommodate [Wi...”
[Essmat2025] paper:paper-9da047bf979d “A critical gap in the current evidence base concerns fentanyl-specific circuit mechanisms. Despite fentanyl's centrality to the current opioid overdose crisis, most preclinical circuit-level studies have used morphine as the prototypical opioid [Essmat2025, Torres2026]. Whether fentanyl's distinct pharmacokinetic profile — faster onset, higher potency, different receptor binding kinetics — engages different circuit...”
[Torres2026] paper:paper-58fd384a5bf1 “A critical gap in the current evidence base concerns fentanyl-specific circuit mechanisms. Despite fentanyl's centrality to the current opioid overdose crisis, most preclinical circuit-level studies have used morphine as the prototypical opioid [Essmat2025, Torres2026]. Whether fentanyl's distinct pharmacokinetic profile — faster onset, higher potency, different receptor binding kinetics — engages different circuit...”
[Patidar2025] paper:paper-107a6fc188ac “A critical gap in the current evidence base concerns fentanyl-specific circuit mechanisms. Despite fentanyl's centrality to the current opioid overdose crisis, most preclinical circuit-level studies have used morphine as the prototypical opioid [Essmat2025, Torres2026]. Whether fentanyl's distinct pharmacokinetic profile — faster onset, higher potency, different receptor binding kinetics — engages different circuit...”
[Fouyssac2025] paper:paper-5b872c45add1 “Among all drug classes, stimulants — cocaine and amphetamines — provide the strongest support for the dopamine convergence model. Cocaine directly blocks the dopamine transporter (DAT), and amphetamines reverse DAT function, both producing rapid, large increases in synaptic dopamine concentrations. If any drug class should validate the "final common pathway," it is this one. Yet even here, the mechanisms extend well...”
[Gomez2025] paper:paper-d32f13914759 “Among all drug classes, stimulants — cocaine and amphetamines — provide the strongest support for the dopamine convergence model. Cocaine directly blocks the dopamine transporter (DAT), and amphetamines reverse DAT function, both producing rapid, large increases in synaptic dopamine concentrations. If any drug class should validate the "final common pathway," it is this one. Yet even here, the mechanisms extend well...”
[Cutler2025] paper:paper-2cbc9ca237b1 “Among all drug classes, stimulants — cocaine and amphetamines — provide the strongest support for the dopamine convergence model. Cocaine directly blocks the dopamine transporter (DAT), and amphetamines reverse DAT function, both producing rapid, large increases in synaptic dopamine concentrations. If any drug class should validate the "final common pathway," it is this one. Yet even here, the mechanisms extend well...”
[Huang2026a] paper:paper-5af5bd1e058c “Glutamatergic plasticity in the prefrontal cortex (PFC)-to-NAc pathway plays a prominent role in cocaine relapse. N-acetylcysteine (NAC), a glutamate-modulating agent, significantly reduced cocaine-seeking behavior on the first day of extinction in rats, though this effect did not persist in subsequent sessions [Huang2026a]. The therapeutic potential of glutamate-modulating agents for treating comorbid stress and co...”
[Cancela2025] paper:paper-c840aba8b2fa “Glutamatergic plasticity in the prefrontal cortex (PFC)-to-NAc pathway plays a prominent role in cocaine relapse. N-acetylcysteine (NAC), a glutamate-modulating agent, significantly reduced cocaine-seeking behavior on the first day of extinction in rats, though this effect did not persist in subsequent sessions [Huang2026a]. The therapeutic potential of glutamate-modulating agents for treating comorbid stress and co...”
[Bedillion2025] paper:paper-58eece9427bb “Glutamatergic plasticity in the prefrontal cortex (PFC)-to-NAc pathway plays a prominent role in cocaine relapse. N-acetylcysteine (NAC), a glutamate-modulating agent, significantly reduced cocaine-seeking behavior on the first day of extinction in rats, though this effect did not persist in subsequent sessions [Huang2026a]. The therapeutic potential of glutamate-modulating agents for treating comorbid stress and co...”
[Carbone2026a] paper:paper-b15a22fd17e3 “Glutamatergic plasticity in the prefrontal cortex (PFC)-to-NAc pathway plays a prominent role in cocaine relapse. N-acetylcysteine (NAC), a glutamate-modulating agent, significantly reduced cocaine-seeking behavior on the first day of extinction in rats, though this effect did not persist in subsequent sessions [Huang2026a]. The therapeutic potential of glutamate-modulating agents for treating comorbid stress and co...”
[Cherubini2022] paper:paper-f350a75041b0 “Alcohol presents a fundamental challenge to the single-target model that underpins addiction pharmacology for other drug classes. Unlike opioids (MOR), stimulants (DAT), nicotine (nAChR), or cannabis (CB1), alcohol acts on multiple molecular systems simultaneously — GABA-A receptors, NMDA receptors, endogenous opioid peptides, nicotinic acetylcholine receptors (nAChRs), 5-HT3 receptors, and GIRK channels, among othe...”
[Xie2025] paper:paper-fca017075c98 “Alcohol presents a fundamental challenge to the single-target model that underpins addiction pharmacology for other drug classes. Unlike opioids (MOR), stimulants (DAT), nicotine (nAChR), or cannabis (CB1), alcohol acts on multiple molecular systems simultaneously — GABA-A receptors, NMDA receptors, endogenous opioid peptides, nicotinic acetylcholine receptors (nAChRs), 5-HT3 receptors, and GIRK channels, among othe...”
[Bell2009] paper:paper-05847d71e023 “Alcohol presents a fundamental challenge to the single-target model that underpins addiction pharmacology for other drug classes. Unlike opioids (MOR), stimulants (DAT), nicotine (nAChR), or cannabis (CB1), alcohol acts on multiple molecular systems simultaneously — GABA-A receptors, NMDA receptors, endogenous opioid peptides, nicotinic acetylcholine receptors (nAChRs), 5-HT3 receptors, and GIRK channels, among othe...”
[Farahbakhsh2026] paper:paper-b1dfab2ca902 “Alcohol presents a fundamental challenge to the single-target model that underpins addiction pharmacology for other drug classes. Unlike opioids (MOR), stimulants (DAT), nicotine (nAChR), or cannabis (CB1), alcohol acts on multiple molecular systems simultaneously — GABA-A receptors, NMDA receptors, endogenous opioid peptides, nicotinic acetylcholine receptors (nAChRs), 5-HT3 receptors, and GIRK channels, among othe...”

Sister wikis (recently updated · no domain on this page)

Recent activity here

No recent events touching this page.